Article Text

Download PDFPDF
Microvascular dysfunction in patients with cardiac syndrome X
  1. Eugene B Wu
  1. Dr Eugene B Wu, Prince of Wales Hospital, Chinese University Hong Kong Ngan Shing Road, Shatin, Hong Kong; ebwu{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Ever since Cannon and Epstein1 coined the term “microvascular angina” to describe syndrome X in 1988, the theory that a significant proportion of patients with syndrome X have microvascular dysfunction that leads to ischaemia, ST-depression, and chest pain has dominated the field of syndrome X research. This is surprising in view of the fact that the studies looking at the presence of ischaemia and microvascular dysfunction are poorly conducted and have inconsistent results. Despite publication bias, there are numerous negative studies demonstrating the lack of ischaemia in syndrome X patients when compared to controls. Indeed when Cannon himself did a well conducted study into microvascular dysfunction and found negative results, he concluded that invasive measurements of endothelium-dependent and endothelium-independent agonists is unlikely to be of value …

View Full Text


  • Competing interests: None.

Linked Articles